The Safety Concerns Shadowing Peptide Growth in Beauty-Wellness Sector

The beauty and wellness industry, now valued at $6.8 trillion, is increasingly incorporating peptides. These compounds appear in a range of products, from costly injections to inexpensive lip balms. However, concerns about their safety and efficacy have arisen.

Concerns from Academia

Researchers at Northeastern University have raised alarms about the rapid adoption of peptides, considering the lack of comprehensive safety evaluations. Their concerns followed a U.S. Food and Drug Administration (FDA) meeting discussing the future of certain peptide compounds. Robert F. Kennedy Jr., the Secretary of the Department of Health and Human Services, has been an advocate for these compounds.

The core question is whether peptides, marketed for various benefits, are actually ready for widespread use.

Popularity and Regulatory Considerations

Interest in peptides has surged, with Americans conducting over 10.1 million peptide-related searches monthly by January. A significant portion of the population, including teenagers, has shown willingness to use peptide-based products.

If the FDA lowers restrictions, specialized pharmacies could compound personalized peptide medications. The Pharmacy Compounding Advisory Committee met in July to review access to certain previously banned peptides.

Emily G. Hilliard, HHS press secretary, remarked, “The committee’s recommendations will guide the FDA’s next steps.” A proposed rule will invite public comments before any final decision is made on the inclusion of substances on the 503A Bulks List.

Earlier in the year, Kennedy Jr. suggested that significant changes could occur, potentially moving numerous peptides off the restricted list in a historic reversal.

Expert Opinions on Peptides

Valerie Aparovich, a certified cosmetologist and biochemist, expressed hope for the potential of topical peptides. She acknowledged, however, that much of the supporting research originates from companies selling these ingredients.

Potential Dangers in Use

Despite optimism, rare harmful incidents linked to peptides have emerged. For example, two women became critically ill at a Las Vegas festival in 2025 after receiving peptide injections from an unlicensed practitioner.

Karthik Achari, founder of PepMD, addressed the challenges at an FDA meeting. He emphasized the absence of rigorous, controlled data supporting peptide safety and warned against the reliance on anecdotal evidence. Achari advocates for a regulated pathway, which he argues is safer than current grey-market alternatives.

Dr. Neil Panchal from Longevitix agreed, stressing the need for regulated pathways to avoid patients resorting to potentially unsafe, unverified products.

Northeastern University’s Mansoor Amiji cautioned that most peptides lack clinical proof of safety and effectiveness. While FDA-approved peptides exist, many marketed claims lack scientific backing.

Potential risks, including hazardous systemic absorption through topical use, further highlight the importance of careful consideration before broad usage.

Steve Kates, also from Northeastern, pointed to major manufacturing and approval hurdles that peptides currently face.